Answers are grounded in this paper and cite their sources.
Objective: Amelogenesis Imperfecta (AI) is a genetic disorder affecting enamel formation, with a prevalence ranging from 1:700 to 1:15,000. The hypoplastic type of AI, in particular, may be associated with ectodermal syndromes and metabolic disorders. The co-occurrence of enamel hypoplasia and nephrocalcinosis was first described in 1972. Nephrocalcinosis, characterized by calcium salt deposition in the renal parenchyma, may be asymptomatic or lead to renal impairment. Randall’s plaques, representing early-stage calcification at the renal papillae, play a key role in the pathogenesis of nephrolithiasis. Case: We present a 21-year-old female with yellow-brown discoloration of the enamel, diagnosed with hypoplastic AI. Further evaluation revealed nephrocalcinosis and Randall’s plaques, despite normal renal function. Her bone mineral density was also reduced. Genetic testing and endocrine assessment were initiated. Potassium citrate therapy was commenced to prevent stone formation. Conclusion: This case underscores the potential of AI to serve as an early clinical marker of systemic disease. A multidisciplinary approach can reveal otherwise silent but clinically significant comorbidities.
No takes yet. Share an insight, caveat, or question.
Güvercin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: